Advisory Team
Ruyi He, Ph.D.
Senior Advisor
Chief Medical Officer at SDIC Fund Management Co. Adjunct Professor of School of Medicine at Tsinghua University. Over 17 years experience at FDA. Served as the Chief Scientist at the center for drug evaluation at the Chinese Food and Drug Administration. Post-doc from NIH.
Cheni Kwok, Ph.D., CLP
Senior Advisor
20+ years of broad operational expertise in the biopharmaceutical sector who has executed 150+ transactions (M&A, strategic partnerships, licensing, spin-offs, and project financing). Currently serving as the Managing Partner and Founder of Linear Dreams LLC, and she was the former SVP of Corporate Development at Poniard Pharmaceuticals. Ph.D. in Human Molecular Genetics from University of Cambridge and BSc in Biotechnology from Imperial College London.
Oliver Kong
Advisor, Chief Medical Officer
Oliver possesses over 25 years of clinical development expertise in the pharmaceutical sector. As the US Chief Medical Officer at IASO BIO Therapeutics, he brings substantial experience from notable positions such as CMO and Group VP at Qilu Pharmaceutical, VP of Clinical Oncology at Hengrui USA, and Global Medical Unit Head for Breast Cancer at Novartis Oncology. His impactful roles at Celgene and Bayer underline his extensive contributions to clinical development within the industry. Oliver's seasoned leadership continues to drive advancements in medicine and pharmaceuticals.
Pete Greaney, Ph.D.
Advisor
20+ years in science and business roles. 12+ years at Celgene, Head Corp Dev at ADC Therapeutics & BOD Overland ADCT. Oncology & immunology experience in small-mid biotechs + MNCs. Global network spans Europe, U.S., Japan and China.
Louis “Lou” Pascarella
Advisor
Lou has a 20+ year track record in Life Science commercialization. He has on multiple occasions, built commercial teams from the ground up. He has managed across Commercial, R&D, Business Development, Manufacturing and Product Life Cycle Management. He is unique in that he has extensive experience in small PE owned Biotech companies as well as with large public companies. Positions Lou has held include US Head of Commercial Operations at Novo Nordisk and most recently, the President and CEO on Innocoll Biotherapeutics. Lou has an MBA from New York University/Stern School of Business
Ludwig Chang
Senior Advisor
Over 35 years of global M&A execution and advisory experience across Asia, Africa, Latin America, EU and USA accumulated through major international investment banks, including JPM, UBS and China Construction Bank.
Kitty Huang
Senior Advisor
CEO of Dabai Doctor, a nationwide mobile on-demand family doctor network in China. Previous experience at Lightspeed and international accounting firms.
Helen Hsu, MD
Chief Medical Officer
Physician with 20+ years of clinical and research experience. 15+ years in medical affairs and clinical trials at BI, Novartis, GSK. General Manager of China Evergrande Group, and Head of Research at Evergrande Hospital Group
Liguo Zhang, Ph.D
Senior Advisor
Director of Research at Institute of Biophysics, Chinese Academy of Sciences. Key opinion leader in infectious diseases.